Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

Similar documents
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations

PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation

Pulmonary We provide answers: The most current ICD-10 and CPT coding instruction ICD-10-CM examples for your specialty Strategies to assist correct co

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

Gastroenterology We provide answers: The most current ICD-10 and CPT coding instruction ICD-10-CM examples for your specialty Strategies to assist cor

SOPs for FDA-Regulated Industry Best Practices to Withstand FDA Expectations

Most Cardiology seminars are sponsored by the State Chapters of the ACC.

Most Cardiology seminars are sponsored by the State Chapters of the ACC.

Most Cardiology seminars are sponsored by the State Chapters of the ACC.

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.

Maintenance Reserves Seminar 2019

Most Peripheral Cardiology seminars are sponsored by the State Chapters of the ACC.

21 CFR Part 11 Compliance for SaaS/Cloud Applications

Technical Aspects of a Leased Asset 2019

Computer System Validation - Reduce Costs and Avoid 483s

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

Packaging and Labeling in Pharmaceutical Production

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

Applying ISO14971 / IEC62304 / IEC A Practical Guide On How To Implement Risk Management

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Designing and Sustaining New and Existing Product Stability Testing Program

Participants of this seminar who pass the optional exam will be eligible for IRF's New Procurement & Contract Professional (Details Coming Soon!

Managing Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an Inspection

1st IRF Regional Conference & Exhibition for Road Safety The Road to Zero

FDA's New Import Program for Strict Precision

Statistical Analysis for Process and Product Development

Managing Your FDA Inspection: Before, During and After

GxP Auditing, Remediation, and Quality System Resourcing

IRF Global R2T Conference & Exhibition. Building the Transport Infrastructure of Tomorrow

Biocompatibility Testing for Medical Devices

Biocompatibility Testing for Medical Devices

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics

GxP Auditing, Remediation, and Staff Augmentation

Risk Based Incoming Quality Assurance (IQA)

Survival Kit for Regulatory Inspections

Tennessee: Leader As Coach: Leadership Development Master Class (BLR)

Agenda: Day 1 Schedule 8:30 AM - 9:00 AM: Registration

GxP Auditing, Remediation, and Staff Augmentation

PAI Inspections, Observations and Data Integrity

Stability Studies for Pharmaceutical Products (API and finished products)

Evaluation and Management Boot Camp Professional Version

Live Florida CME Live Florida CE & CME in Bonita Springs for 15 Contact Hours

Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

Process Validation for FDA Regulated Industries

2019 Revenue Integrity Symposium

Focused Trends from the FDA

Root Cause Analysis and CAPA using 8-D Problem Solving Method

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

2nd Annual Mining Investment North America

Certified Chief Information Security Officer (CCISO)

This live CE / CME experience is accredited for MDs, PAs, Pharms, Pharm Techs, NPs and Nurses!

Medicare Boot Camp Provider-Based Departments Version

Medicare Boot Camp Rural Health Clinic Version

Medicare Boot Camp Rural Health Clinic Version

Medicare Boot Camp Rural Health Clinic Version

2ND ANNUAL INVESTMENT EUROPE

Statistical Process and Quality Control

International Trade Finance

3rd Annual Mining Investment India

Companies are realizing the value of. cost-effective option. an opinion regarding a business company performance.

Residency Program Coordinator Boot Camp

International Trade Finance

Safety Culture 2019 (BLR)

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach

2 Day Seminar. Supplier Management for Medical Device Manufacturers 12 RAPS CREDITS. Jun Boston

National Conference on Student Leadership

Health Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

Medicare Boot Camp Long-Term Care Version

Medicare Boot Camp Long-Term Care Version

Medicare Boot Camp Long-Term Care Version

HR World 2019 *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY!

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries

Join us at an invaluable platform to seek new partnerships, new business and new opportunities.

An Introduction to Double Dragon Consulting

Preventing, Detecting, and Responding to Data Integrity Events. Background, Recent Findings, and Agency Expectations

Bring this workshop to your location: For more information, contact PharmaEd Resources at (217) PharmaED

FCTA th International Conference on Fuzzy Computation Theory and Applications

ICISSP 2020, 6th Int. Conf. on Information Systems Security and Privacy

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

2 Day Seminar Assuring Data Integrity in the Life Science industry. Manufacturers

Shanghai Event Program Change Table Sessions Creative Spark

Barcelona Event Program Change Table Sessions Creative Spark

KDIR th International Conference on Knowledge Discovery and Information Retrieval

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Colorado: Leader As Coach: Leadership Development Master Class

Process Validation. Instructor Philip K. Ngai, Ph.D.* Senior Advisor & Trainer. National University of Singapore Academy of GxP Excellence (NUSAGE)

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program COMPUTERIZED SYSTEM VALIDATION

FOREIGN DRUG INSPECTION/AUDITS FROM THE FDA PERSPECTIVE

Effective Risk Management in Aircraft Leasing and Aviation Finance 2019

Resilience Training: Psychological Survival Skills for Before, During and After Crises 8:30 AM - 5:00 PM Glenn Schiraldi

NEW! Processing of cgmp Controlled Raw Materials

Transcription:

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION The globalization of the pharmaceutical supply chain has led increased use of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it can present unique compliance risks, particularly since the operations are not in your facility and therefore not under your direct control. The compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious compliance and data integrity issues at foreign CMO sites. If you use CMOs, your company has the ultimate responsibility for product quality, safety, efficacy, and cgmp compliance. Furthermore, FDA has clearly stated that organizations using CMOs will be held accountable for CMO compliance to cgmps, as well as adherence to regulatory commitments. Therefore, issues identified at your CMO may result in FDA 483s and/or Warning Letters issued to your company. Since FDA is holding firms using CMOs responsible, it is imperative that your organization have a robust CMO management system. At the end of the day, your organization s ability to provide proper quality oversight of CMOs is the key to assuring product safety and your company s compliance profile. This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, Quality Agreements, Understanding of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be discussed. This is a practical how-to course, designed to provide participants with skills they can immediately apply to CMO oversight within their own organizations. Group exercises will allow participants to practice skill sets with feedback from the instructor. Learning Objectives: Upon completing this course, participants should be able to: Understand the CMO business model Learn the regulatory requirements for CMO quality oversight Learn how to structure your organization for effective CMO oversight Learn key points for selecting and qualifying CMOs Learn how to prepare for and conduct CMO Qualification Audits Learn how to develop a Quality Agreement and how to execute it Learn how to understand CMO operations Learn key points for reviewing CMO records Learn how to resolve issues identified in CMO records Learn how to prepare for and conduct routine CMO audits Learn how to manage CMOs on an ongoing basis Who will Benefit: This course is designed for people tasked with oversight of these CMO functions: Manufacturing operations Quality Control operations Quality Assurance operations The following personnel will benefit from the course: Pharmaceutical Development

Quality Control Validation Regulatory Affairs Quality Assurance Project Management AGENDA Day 01(8:00 AM - 4:30 PM) Registration Process: 8:30 AM 9:00 AM Session Start Time: 9:00 AM The CMO Business Model What is CMO Oversight? Regulatory Requirements for CMO Oversight FDA Expectations and Warning Letters Structuring Your Organization for CMO Oversight Manufacturing Chemistry / Laboratory Quality Assurance Regulatory Affairs Project Management Group Exercise # 1- Structuring Your Organization CMO Selection and Qualification Key Selection / Qualification Criteria Overall Considerations Considerations for API CMOs Considerations for Drug Product CMOs Considerations for Aseptic Manufacturing CMOs Considerations for Testing Laboratory CMOs Evaluating CMOs vs. Selection / Qualification Criteria Group Exercise # 2- CMO Selection and Qualification CMO Qualification Audits Overall Considerations for CMO Qualification Audits CMO Questionnaires Risk Assessments for Use of Questionnaires Evaluation of Questionnaire Responses Audit Planning Auditor Selection Determining Audit Purpose / Scope Audit Agenda Audit Execution Introductory Meeting / Orientation Area Tours Document Review / Interviews Time Management Audit Findings Group Exercise # 3- Audit Agenda The Quality Agreement Regulatory Requirements Elements of the Quality Agreement Negotiating the Quality Agreement

Executing the Quality Agreement Group Exercise # 4- Quality Agreement Day 02(8:00 AM - 4:30 PM) Getting to Know Your CMO Understanding CMO Operations Operational/Communication Style How to Deal with the Seven CMO Personality Types Review of Key CMO Records Batch Records Change Controls Group Exercise # 5- Change Control Critique Deviation Investigations / CAPA Group Exercise # 6- Deviation Investigation Critique OOS Investigations Group Exercise # 7- OOS Investigation Critique Hot Topic- Data Integrity Routine CMO Audits Audit Planning Audit Execution Differences from CMO Qualification Audits Ongoing CMO Oversight Overall Considerations Elements of Effective Ongoing CMO Oversight SPEAKER Andrew Campbell Pharmaceutical Consultant - Quality & Compliance Andrew Campbell has 25 years of pharmaceutical quality assurance and quality systems experience in both industry and consulting roles. Mr. Campbell has worked in clinical supply and commercial manufacturing environments, and has experience with integrated manufacturing and contract manufacturing business models. He has extensive expertise in the areas of deviation - CAPA, change control, GMP auditing, GMP training, and regulatory inspection preparation and management. Working with large and small companies, Mr. Campbell has successfully developed, remediated and implemented key quality systems. He is a skilled GMP auditor, and has audited multiple API, drug product, packaging, testing, and distribution facilities. He is an experienced GMP trainer, and has developed customized and interactive training presentations for many companies. He has also provided FDA inspection support for several clients, including readiness training, on-site assistance during inspections, and authoring written responses to inspectional observations. Prior to becoming a consultant in 2007, Mr. Campbell worked for Ligand Pharmaceuticals as director of quality systems. PARTNERS/SPONSORS We are pleased to offer several exhibitor, sponsorship and media partnership options designed to maximize your company's exposure and networking opportunities before,

during and after the event. Benefits of becoming a Sponsor/Exhibitor/Media Partner: Logo on website, marketing email, branding materials & the registration booth Logo on website, marketing email, branding materials & the registration booth Exhibit Space Free event pass Speaking opportunity Social media campaign Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for: - Multiple participant discounts - Price quotations or visa invitation letters - Payment by alternate channels (PayPal, check, Western Union, wire transfers etc) - Event sponsorships NO REFUNDS/TRANSFERS ALLOWED ON REGISTRATIONS Prices may go up any time. Service fees included in pricing. ----------------------------------------------------------------- This event is brought to you by: ComplianceOnline.com - NewYorkEventsList http://www.nyeventslist.com http://www.bostoneventslist.com http://www.sfbayeventslist.com ----------------------------------------------------------------- JOA190513CEV